Gary Clark: Unfiltered

Symbotic's $630M stock offering raises capital and questions. We analyze the dual move: funding AI dominance while its top backer cashes in some chips.

With Cantor Fitzgerald's backing, Twenty One Capital's NYSE debut as a 'Bitcoin-native' firm marks a new chapter for institutional crypto investment.

Carrier's big dividend increase isn't just a payout. It's a bold statement about its cash flow, strategic pivot to sustainability, and future growth.

Delving into MIND Technology's $9.5M contract, we uncover the forces driving a resurgence in offshore exploration and the niche tech leading the charge.

Celanese Corporation's upsized debt offering reveals a savvy strategy to extend maturities and boost liquidity, signaling deep market confidence.

GigaCloud Technology is acquiring New Classic Home Furnishings. We unpack the strategy behind this cash-rich tech firm's move into traditional retail.

The EU's new ResourceEU plan mobilizes billions to break foreign supply chain dominance, putting projects like Rock Tech's Guben lithium plant at the fore.

Beyond observability, Dynatrace's new AI agents and AWS specialization signal a strategic push into autonomous cloud operations. What does this mean for investors?

From orphan drugs to the massive obesity market, we unpack Hoth Therapeutics' ambitious four-front strategy and the financial currents driving this biotech.

By repaying debt early, Interpace signals a successful turnaround. See how financial discipline is fueling its focused push into thyroid diagnostics.

An activist investor accuses Dye & Durham's board of entrenchment, launching a proxy fight to install a turnaround team and force a strategic reckoning.

Malaysia's Treasure Global is consolidating its stock to stay on Nasdaq. But can this financial fix address the deep-seated challenges facing its ZCITY app?

Venu Holding's explosive growth and record sales from AEO and ANF reveal a resilient consumer, challenging recession fears with strong spending on experiences and retail.

With promising clinical data and key FDA backing, Lantern Pharma's AI-driven strategy is targeting a lucrative, underserved niche in precision oncology.

Bitget pairs football star Julián Alvarez with its AI trader, GetAgent. Is this a winning marketing goal or a risky play in a tightening regulatory field?

With an $854 CMS payment rate, Cardio Diagnostics gets a lifeline. This move could be a blueprint for how AI-driven medical tech gets funded.

Alpha Modus's patent suit against H&M is more than a legal fight; it’s a battle over the foundational rules of retail's multi-billion dollar AI future.

A landmark robotics deal between UAE's Micropolis and Saudi's QSS could reshape regional security and supercharge Vision 2030. But what's behind the LOI?

New data shows a non-invasive light-and-sound therapy may boost brain resilience and slow Alzheimer's, positioning it as a disruptive force in the market.

Garrett Motion's $250M share repurchase signals deep financial confidence, but the real story is how it balances shareholder returns with a bold pivot to EV tech.